Search - tctmd.com

Displaying 21 - 40 of 300

Sort: Relevancy | Date

Presentation THT 2025

Role of MCS in PE Management

Presenter: Karthikeyan Ranganathan

February 12, 2025

Presentation THT 2025

Medical Management (Heparin/ Lytics)

Presenter: Gregory Piazza

February 12, 2025

Presentation THT 2025

Invasive Therapies (Inari/EKOS)

Presenter: Sareena George

February 12, 2025

Presentation THT 2025

Clinical Trial Updates: What's New? What's Coming?

Presenter: Jay Giri

February 12, 2025

Presentation THT 2025

Case Resolution and Discussion

Presenter: Maya Serhal

February 12, 2025

Presentation THT 2025

Case Presentation: Submassive PE With Normotensive Shock

Presenter: Maya Serhal

February 12, 2025

Presentation THT 2025

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Presenter: Eric Secemsky

February 12, 2025

Presentation THT 2025

Patients With Heart Failure Implanted With a Pulmonary Artery Pressure Sensor: Hemodynamic and Clinical Outcomes From the HF2 Registry

Presenter: Timothy Jordan

February 12, 2025

Presentation THT 2025

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Presenter: Barry Borlaug

February 12, 2025

Presentation THT Abstracts 2025

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

Presenter: Van-Khue Ton

February 11, 2025

Presentation THT 2025

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Presenter: Alexis Barnes

February 11, 2025

Presentation THT 2025

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

Presenter: Gabrielle Daso

February 11, 2025

Presentation THT 2025

The Percutaneous Synchronized Cardiac Assist (PSCA) System for Extravascular Mechanical Circulatory Support: A Safety and Hemodynamic Performance Study

Presenter: Petr Neuzil

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Presenter: Matteo Pagnesi

February 11, 2025

Presentation THT 2025

Hemodynamic Impact of Ventricular Tachycardia After Transcatheter Edge-to-Edge Mitral Repair: Insights From Pressure-Volume Loop Monitoring

Presenter: Giulio Mondellini

February 11, 2025

Presentation THT 2025

Expanding Indications and Options for Ambulatory Hemodynamic Monitoring: Lessons From GUIDE-HF and PROACTIVE-HF

Presenter: Liviu Klein

February 11, 2025

Presentation THT 2025

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Presenter: Manreet Kanwar

February 11, 2025

Advertisement

Role of MCS in PE Management

Medical Management (Heparin/ Lytics)

Invasive Therapies (Inari/EKOS)

Clinical Trial Updates: What's New? What's Coming?

Case Resolution and Discussion

Case Presentation: Submassive PE With Normotensive Shock

Acute PE Risk Stratification: Where Do Hemodynamics Fit In?

Patients With Heart Failure Implanted With a Pulmonary Artery Pressure Sensor: Hemodynamic and Clinical Outcomes From the HF2 Registry

How Does Weight Loss Improve Hemodynamics in Patients With HFpEF

Normalized Hemodynamics and Unique Pressure/Flow Relationships at Submaximal Exercise in Left Ventricular Assist Device-Supported Patients

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Characteristics and Outcomes of Patients With Impella 5.5 Complicated by Stroke: A Cardiogenic Shock Working Group Analysis

Cardiac Recovery in Cardiogenic Shock Patients Treated With Impella 5.5

Acute Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Decompensated Heart Failure on Hepatorenal Function

The Percutaneous Synchronized Cardiac Assist (PSCA) System for Extravascular Mechanical Circulatory Support: A Safety and Hemodynamic Performance Study

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Hemodynamic Impact of Ventricular Tachycardia After Transcatheter Edge-to-Edge Mitral Repair: Insights From Pressure-Volume Loop Monitoring

Expanding Indications and Options for Ambulatory Hemodynamic Monitoring: Lessons From GUIDE-HF and PROACTIVE-HF

Protek Duo or Impella RP: Which One and Why in Biventricular Shock?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content